أثر منح البراءة للإختراعات الدوائية على الدول النامية في ظل إتفاقية تريبس

Abstract EN

The right to medicine is considered one of the basic human rights, but this right has become exclusive under the intellectual property rights (patent system, undisclosed information, marks, new plant varieties).

Perhaps the most important agreements in the current century to protect these rights is the TRIPS Agreement, as it introduced new international rules and obligated member states to protect the medicinal product, the method of manufacture, as well as the testing data, but imparting protection to these products may limit the ability of developing countries to provide medicine to their people.

However, these countries should take advantage of the flexibilities in the agreement when enacting their legal system related to intellectual property and uniting their ranks when drafting international rules related to intellectual property.